BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18166477)

  • 21. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy.
    Smith FM; Reynolds JV; Miller N; Stephens RB; Kennedy MJ
    Eur J Surg Oncol; 2006 Feb; 32(1):55-64. PubMed ID: 16324817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
    Brabender J; Arbab D; Huan X; Vallböhmer D; Grimminger P; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
    Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is p53 and heat shock protein 70 expression a useful parameter for preoperative hyperthermoradiation therapy in advanced rectal carcinoma.
    Takeuchi K; Nakajima M; Miyazaki T; Ide M; Asao T; Fujita K; Kuwano H
    Hepatogastroenterology; 2007 Mar; 54(74):367-72. PubMed ID: 17523276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of doxorubicin sensitivity in gastric cancers based on a set of novel markers.
    Liu H; Li N; Yao L; Jiang L; Bao G; Li J; Ma Q; Liu Z
    Oncol Rep; 2008 Oct; 20(4):963-9. PubMed ID: 18813841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
    Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
    Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status.
    Kulkarni T; Gollins S; Maw A; Hobson P; Byrne R; Widdowson D
    Colorectal Dis; 2008 Jun; 10(5):479-89. PubMed ID: 18318754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer gene profiling for response prediction.
    Ghadimi BM; Grade M
    Methods Mol Biol; 2010; 576():327-39. PubMed ID: 19882269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole.
    Miller WR; Larionov A; Renshaw L; Anderson TJ; Walker JR; Krause A; Sing T; Evans DB; Dixon JM
    J Clin Oncol; 2009 Mar; 27(9):1382-7. PubMed ID: 19224856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy.
    Kittleson MM; Ye SQ; Irizarry RA; Minhas KM; Edness G; Conte JV; Parmigiani G; Miller LW; Chen Y; Hall JL; Garcia JG; Hare JM
    Circulation; 2004 Nov; 110(22):3444-51. PubMed ID: 15557369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis.
    Harima Y; Togashi A; Horikoshi K; Imamura M; Sougawa M; Sawada S; Tsunoda T; Nakamura Y; Katagiri T
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):237-48. PubMed ID: 15337562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity.
    Svensson JP; Stalpers LJ; Esveldt-van Lange RE; Franken NA; Haveman J; Klein B; Turesson I; Vrieling H; Giphart-Gassler M
    PLoS Med; 2006 Oct; 3(10):e422. PubMed ID: 17076557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profiling of rectal tumors defines response to neoadjuvant treatment related genes.
    Palma P; Cano C; Conde-Muiño R; Comino A; Bueno P; Ferrón JA; Cuadros M
    PLoS One; 2014; 9(11):e112189. PubMed ID: 25380052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of lymphatic metastasis based on gene expression profile analysis after brachytherapy for early-stage oral tongue carcinoma.
    Watanabe H; Mogushi K; Miura M; Yoshimura R; Kurabayashi T; Shibuya H; Tanaka H; Noda S; Iwakawa M; Imai T
    Radiother Oncol; 2008 May; 87(2):237-42. PubMed ID: 18222011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer.
    Caudle AS; Kim HJ; Tepper JE; O'Neil BH; Lange LA; Goldberg RM; Bernard SA; Calvo BF; Meyers MO
    Ann Surg Oncol; 2008 Jul; 15(7):1931-6. PubMed ID: 18418656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.
    Rème T; Hose D; De Vos J; Vassal A; Poulain PO; Pantesco V; Goldschmidt H; Klein B
    BMC Bioinformatics; 2008 Jan; 9():16. PubMed ID: 18190711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
    Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
    Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.